Search results for: communication

FDA Updates Boxed Warning of Benzodiazepines, Adding Risks for Abuse & Addiction

Michele B. Kaufman, PharmD, BCGP | October 7, 2020

The FDA is requiring all benzodiazepines to carry an updated boxed warning that addresses the risks of misuse, abuse and addiction associated with their use.

New Classification Criteria Describe Several Hereditary Fevers

Larry Beresford | September 21, 2020

Evidence-based classification criteria for rare, hereditary, autoinflammatory fevers have been developed to aid clinicians in better understanding the differences between these rare conditions.

Providers & Patients Talk to Legislators about Telehealth, Workforce Shortage

Carina Stanton | September 18, 2020

On Sept. 15, rheumatology advocates met virtually with members of Congress to share personal accounts of how telehealth is making a difference during the COVID-19 pandemic and what will help stem a workforce shortage.

Best Practices for COVID-19 Regulatory Waivers, Relief Funding & Audits

Steven M. Harris, Esq. | September 11, 2020

When the first laboratory-confirmed COVID-19 case was reported by the Centers for Disease Control & Prevention (CDC) on Jan. 22, it was difficult to predict an ensuing global pandemic would last for more than half the year. Approximately one week after the initial CDC report, the U.S. Department of Health & Human Services (HHS) declared…

Measuring & Preventing Diagnostic Errors

Richard Zamore, MD, MPH | September 11, 2020

In a December 2019 editorial in the Journal of the American Medical Association, the implications of diagnostic error were explored through the story of two parents, both medical professionals, who sought a diagnosis for their sick child.1 Their son saw specialist after specialist and underwent repeated procedures, but for years was left without an explanation…

Staying Connected with Constituents During COVID-19

Vanessa Caceres | September 4, 2020

Legislative staff talk about working during the pandemic and how they are connecting with constituents.

2021 Merit-Based Incentive Payment System Payment Adjustments, Explained

Allison Plitman | September 4, 2020

Many clinicians are receiving smaller reimbursements than expected for their 2021 Merit-Based Incentive Payment System adjustments. Available funding is extremely limited due to the high number of clinicians who were unable to report 2019 MIPS data and accepted the automatic neutral payment under the extreme and uncontrollable circumstances policy.

Guidance Coming for Anticipated COVID-19 Vaccine

Carina Stanton | September 4, 2020

What to vaccinate for and when to do so are challenges for rheumatologists and rheumatology professionals under normal circumstances. During the COVID-19 pandemic, even more questions are being raised, specifically regarding a possible vaccine for SARS-CoV-2. The ACR’s COVID-19 Practice and Advocacy Task Force is working on a guidance document to help ACR members address these pressing questions.

Advocacy 101 Teaches Legislative, Advocacy Basics

Vanessa Caceres | August 21, 2020

Bharat Kumar, MD, Advocacy 101 coordinator and Government Affairs Committee member, describes the virtual program designed to educate and empower rheumatology fellows in training, program directors and ARP members to advocate for issues that affect rheumatology practices and patients in advance of the Advocates for Arthritis that will take place virtually in September.

ACR Leaders Discuss Hydroxychloroquine Issues with FDA Commissioner

From the College | August 10, 2020

The conversation with Stephen Hahn, MD, addressed challenges associated with hydroxychloroquine access during the COVID-19 public health emergency and handling patient concerns about potential cardiac side effects.